Original ArticleA Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients
Under a Creative Commons license
open archive
Key words:
Clinical research
dysfunction
immune modulation
immunosuppression
immunosuppressive regimens
kidney (allograft) function
kidney transplantation
maintenance
meta-analysis
minimization
nephrology
practice
withdrawal
Abbreviations
BPAR
biopsy-proven acute rejection
CAN
chronic allograft nephropathy
CI
confidence interval
CMV
cytomegalovirus
CNI
calcineurin inhibitor
CVD
cardiovascular disease
df
degree of freedom
DFG
death with functioning graft
IFTA
interstitial fibrosis and tubular atrophy
ITT
intention to treat
MPA
mycophenolic acid
mTORi
mammalian target of rapamycin inhibitor
NODAT
new-onset diabetes after transplantation
OT
on-treatment
RCT
randomized controlled trial
RR
risk ratio
WMD
weighted mean difference
Cited by (0)
Copyright © 2014 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.